State Of Wisconsin Investment Board Shattuck Labs, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$1.37 - $7.24 $17,673 - $93,396	-12,900 Reduced 34.68%	24,300 $173,000
Q3 2023 Nov 14, 2023	SELL	$1.42 - $3.16 $4,544 - $10,112	-3,200 Reduced 7.92%	37,200 $56,000
Q2 2023 Aug 14, 2023	SELL	$2.52 - $3.66 $11,088 - $16,104	-4,400 Reduced 9.82%	40,400 $126,000
Q1 2023 May 15, 2023	SELL	$2.5 - $4.72 $20,500 - $38,704	-8,200 Reduced 15.47%	44,800 $131,000
Q4 2022 Feb 14, 2023	SELL	$1.96 - $3.26 $22,148 - $36,838	-11,300 Reduced 17.57%	53,000 $121,000
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.52 $58,240 - $123,647	-22,400 Reduced 25.84%	64,300 $174,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $4.59 $17,550 - $29,835	-6,500 Reduced 6.97%	86,700 $352,000
Q1 2022 May 13, 2022	BUY	$4.22 - $8.89 $248,135 - $522,732	58,800 Added 170.93%	93,200 $397,000
Q3 2021 Nov 12, 2021	BUY	$17.57 - $28.95 $15,321 - $25,244	872 Added 2.6%	34,400 $701,000
Q2 2021 Aug 12, 2021	BUY	$24.14 - $37.68 $809,365 - $1.26 Million	33,528 New	33,528 $972,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.